Statistics on NHS Stop Smoking Services - England, April 2010 to September 2010, Q2, Quarterly report

• 341,455 people set a quit date through NHS Stop Smoking Services, a decrease of 3% (11,820) on the final figure for same period in 2009/10 (353,275), and an increase of 17 per cent (48,377) on the final figure for the same period in 2008/09 (293,078).
• At the 4 week follow-up 162,253 people had successfully quit (based on self-report), 48 per cent of those setting a quit date. This is a decrease of 4 per cent (6,947) on the final figure for the same period in 2009/10 (169,200), but an increase of 12 per cent (17,980) on the final figure for the same period in 2008/09 (144,273).
• *71 per cent of successful quitters at the 4 week follow-up had their results confirmed by Carbon Monoxide (CO) verification . This percentage was 68 per cent based on final figures for the same period in 2009/10 and 66 per cent based on final figures for the same period in 2008/09.
• Of those setting a quit date, success at the four week follow-up increased with age, from 33 per cent of those aged under 18, to 55 per cent of those aged 60 and over.
• Of those setting a quit date, success at the four week follow-up increased with age, from 33 per cent of those aged under 18, to 55 per cent of those aged 60 and over.
• Of the 10,429 pregnant women who set a quit date, 4,474 successfully quit at the four week follow-up (43 per cent).
• **The majority of those setting a quit date received Nicotine Replacement Therapy (NRT) only (62 per cent). A further 26 per cent received varenicline (Champix) only, 1 per cent received bupropion (Zyban) only, 1 per cent received both NRT and varenicline and less than 1 per cent received both NRT and bupropion. 6 per cent of people setting a quit date did not receive any pharmacotherapy and the type of treatment was unknown for a further 3 per cent.
• Of those who used varenicline 59 per cent successfully quit, compared with 52 per cent who received bupropion only, and 44 per cent who received NRT only. 47 per cent of people who did not receive any type of pharmacotherapy successfully quit. (These data should not be used to assess or compare the clinical effectiveness of the various pharmacotherapies as they reflect only the results obtained through the NHS stop smoking services, and are not based on clinical trials. A trained stop smoking advisor discusses and agrees the treatment option with each client.)
• Total expenditure on NHS Stop Smoking Services was £40.4 million, an increase of 0 per cent (£0.1 million) on the final figure for the same period in 2009/10 (£40.3 million) and an increase of 23 per cent (£7.6 million) on the final figure for the same period in 2008/09 (£32.8 million). The cost per quitter is £249 compared with £238 based on final figures for the same period in 2009/10 and £227 based on final figures for the same period in 2008/09. These figures do not include expenditure on pharmacotherapies.
• Among Strategic Health Authorities (SHAs), the South Central SHA reported the highest proportion of successful quitters (53 per cent), while North East SHA and West Midlands SHA reported the lowest success rate (43 per cent).
• Among Primary Care Trusts (PCTs), Sheffield PCT reported the highest proportion of successful quitters (73 per cent), while Camden PCT reported the lowest success rate (23 per cent).
• For Quarter 2 in 2009/10, the increase between the provisional figures and the final figures was 7.3 per cent for the number setting a quit date and 7.9 per cent for the number of successful quitters (based on self-report). This suggests that the final figures for 2010/11 may be higher than the provisional figures stated above.
• For Quarter 2 in 2009/10, there was a increase of 1.7 per cent between the provisional and final Quarter 2 expenditure figure.

* Carbon Monoxide (CO) validation measures the level of carbon monoxide in the bloodstream and provides an indication of the level of use of tobacco: it is a motivational tool for clients as well as validation of their smoking status. CO validation should be attempted on all clients who self-report as having successfully quit at the 4-week follow-up, except those who were followed up by telephone.

** These data should not be used to assess or compare the clinical effectiveness of the various pharmacotherapies as they reflect only the results obtained through the NHS Stop Smoking Services, and are not based on clinical trials. A trained stop smoking advisor discusses and agrees the treatment option with each client.